Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?
Saved in:
Published in | Journal of thoracic oncology Vol. 20; no. 3; pp. e41 - e42 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.03.2025
|
Online Access | Get full text |
ISSN | 1556-0864 1556-1380 1556-1380 |
DOI | 10.1016/j.jtho.2024.11.017 |
Cover
Author | Sun, Nan He, Jie Li, Dongyu Zhang, Chaoqi Wu, Peng |
---|---|
Author_xml | – sequence: 1 givenname: Peng surname: Wu fullname: Wu, Peng organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China – sequence: 2 givenname: Dongyu surname: Li fullname: Li, Dongyu organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China – sequence: 3 givenname: Chaoqi surname: Zhang fullname: Zhang, Chaoqi organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China – sequence: 4 givenname: Nan surname: Sun fullname: Sun, Nan organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China – sequence: 5 givenname: Jie surname: He fullname: He, Jie email: prof.jiehe@gmail.com organization: Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40049767$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtLxDAUhYMovv-AC8nSzdQkTdqOCDIUXzCM4gOXIU1unZRpMyap4L-3w4y6c3UPN98JyTkHaLtzHSB0QklCCc3Om6SJc5cwwnhCaUJovoX2qRDZiKYF2d5oUmR8Dx2E0BDCBeHFLtrjgxznWb6P7KOKFroY8JuNc_wEAXRU1QLw7Lmclvi1M-Dfne3e8QycMk3_qbqIyzm0zrZt37k4B6-WXxf4xeHJz7nzeOYijn-rqyO0U6tFgOPNPESvN9cv5d1o-nB7X06mI83SPI40aKaEMGZcawFcZEQoRQjJWK01DI_WYmyqSnMOADURohbKmIKN07wqKmDpITpb37v07qOHEGVrg4bFQnXg-iBTmvOCUVqs0NMN2lctGLn0tlX-S_7EMwBsDWjvQvBQ_yKUyFUHspGrDuSqA0mpHDoYTJdrEwy__LTgZdBDxBqM9UO40jj7n_0bxiKQiQ |
Cites_doi | 10.1186/s12874-021-01308-8 10.1001/jamaoncol.2017.2797 10.1001/jamanetworkopen.2024.1285 10.1016/j.jtho.2024.09.1443 10.1001/jamaoncol.2022.5816 |
ContentType | Journal Article |
Copyright | 2024 International Association for the Study of Lung Cancer |
Copyright_xml | – notice: 2024 International Association for the Study of Lung Cancer |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.jtho.2024.11.017 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1556-1380 |
EndPage | e42 |
ExternalDocumentID | 40049767 10_1016_j_jtho_2024_11_017 S1556086424024808 |
Genre | Letter Correspondence |
GroupedDBID | --- .55 .XZ .Z2 0R~ 457 53G 5GY 5VS AAEDW AAKAS AALRI AAWTL AAXUO AAYWO ABBUW ABJNI ABMAC ABPMR ACDDN ACGFS ACWDW ACWRI ADBBV ADBIZ ADEZE ADVLN ADZCM AE3 AENEX AEXQZ AFETI AFJKZ AFTJW AFTRI AGCQF AGHFR AITUG AIZYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP BOYCO C45 CS3 DU5 E.X EBS EJD EX3 F5P FDB FL- HZ~ IN~ KD2 NTWIH O9- OFXIZ OGEVE OK1 OVD P2P ROL S4S SSZ TEORI V2I W3M WOQ WOW X7M AAYXX ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP CITATION AACTN NPM 7X8 EFKBS |
ID | FETCH-LOGICAL-c237t-cec2a55dd9fc5e45605aa00062fcce976c59dbbc44eeef055f5add82937b8be23 |
ISSN | 1556-0864 1556-1380 |
IngestDate | Fri Sep 05 12:01:18 EDT 2025 Sat Mar 08 01:23:54 EST 2025 Tue Jul 01 04:57:27 EDT 2025 Sat Jun 07 17:02:24 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c237t-cec2a55dd9fc5e45605aa00062fcce976c59dbbc44eeef055f5add82937b8be23 |
Notes | content type line 23 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 |
PMID | 40049767 |
PQID | 3174821182 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_3174821182 pubmed_primary_40049767 crossref_primary_10_1016_j_jtho_2024_11_017 elsevier_sciencedirect_doi_10_1016_j_jtho_2024_11_017 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | March 2025 2025-03-00 2025-Mar 20250301 |
PublicationDateYYYYMMDD | 2025-03-01 |
PublicationDate_xml | – month: 03 year: 2025 text: March 2025 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of thoracic oncology |
PublicationTitleAlternate | J Thorac Oncol |
PublicationYear | 2025 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Liu, Zhou, Lee (bib3) 2021; 21 Marinelli, Nuccio, Di Federico (bib1) 2025; 20 Pak, Uno, Kim (bib5) 2017; 3 Yap, Leone, Wong (bib4) 2023; 9 Zhou, Li, Yu (bib2) 2024; 7 Liu (10.1016/j.jtho.2024.11.017_bib3) 2021; 21 Pak (10.1016/j.jtho.2024.11.017_bib5) 2017; 3 Zhou (10.1016/j.jtho.2024.11.017_bib2) 2024; 7 Marinelli (10.1016/j.jtho.2024.11.017_bib1) 2025; 20 Yap (10.1016/j.jtho.2024.11.017_bib4) 2023; 9 |
References_xml | – volume: 9 start-page: 215 year: 2023 end-page: 224 ident: bib4 article-title: Effectiveness of immune checkpoint inhibitors in patients with advanced esophageal squamous cell carcinoma: a meta-analysis including low pd-l1 subgroups publication-title: JAMA Oncol – volume: 20 start-page: 285 year: 2025 end-page: 295 ident: bib1 article-title: Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis publication-title: J Thorac Oncol – volume: 3 start-page: 1692 year: 2017 end-page: 1696 ident: bib5 article-title: Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio publication-title: JAMA Oncol – volume: 21 start-page: 111 year: 2021 ident: bib3 article-title: Ipdfromkm: reconstruct individual patient data from published Kaplan-Meier survival curves publication-title: BMC Med Res Methodol – volume: 7 year: 2024 ident: bib2 article-title: Neoadjuvant-adjuvant vs neoadjuvant-only pd-1 and pd-l1 inhibitors for patients with resectable NSCLC: an indirect meta-analysis publication-title: JAMA Netw Open – volume: 21 start-page: 111 year: 2021 ident: 10.1016/j.jtho.2024.11.017_bib3 article-title: Ipdfromkm: reconstruct individual patient data from published Kaplan-Meier survival curves publication-title: BMC Med Res Methodol doi: 10.1186/s12874-021-01308-8 – volume: 3 start-page: 1692 year: 2017 ident: 10.1016/j.jtho.2024.11.017_bib5 article-title: Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2017.2797 – volume: 7 year: 2024 ident: 10.1016/j.jtho.2024.11.017_bib2 article-title: Neoadjuvant-adjuvant vs neoadjuvant-only pd-1 and pd-l1 inhibitors for patients with resectable NSCLC: an indirect meta-analysis publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2024.1285 – volume: 20 start-page: 285 year: 2025 ident: 10.1016/j.jtho.2024.11.017_bib1 article-title: Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis publication-title: J Thorac Oncol doi: 10.1016/j.jtho.2024.09.1443 – volume: 9 start-page: 215 year: 2023 ident: 10.1016/j.jtho.2024.11.017_bib4 article-title: Effectiveness of immune checkpoint inhibitors in patients with advanced esophageal squamous cell carcinoma: a meta-analysis including low pd-l1 subgroups publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2022.5816 |
SSID | ssj0045048 |
Score | 2.4405544 |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | e41 |
Title | Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant? |
URI | https://dx.doi.org/10.1016/j.jtho.2024.11.017 https://www.ncbi.nlm.nih.gov/pubmed/40049767 https://www.proquest.com/docview/3174821182 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVgk6a9IL5XvmQk3qJUqWM3KS-oqkATgwpBJ_YW2Y69thLxKMkD_HquY7sJK0XAS1Q5bdr4nF4f2-feIPRCMw4Dlx7HWo9YTPlkFAs9GsU6U4SWqchS3bot5uPTc_r2gl10O7ptdkkthvLHb_NK_gdVaANcbZbsPyC7vSg0wGvAF46AMBz_CuMPriiq9bDWy9ZEJ-s2FWr-afZuFrXPNLo0djFgrgwv1w3I5jqyNQLMyuaF-OyrtujTwkTT8A6zieamtrI0NF3z__VkbL0EEsmVjEwlf12ib5z_1w-N1vTjktpNdfm92Vmwni25-brq9qgqH_v7yxKEdb6sofKh1FU4TPqxliQ9TqW9wKlc-audgO7WFtZwe0ubqkno0NZcdemePYSvvrQQ24AE-irrBret5TCcuokOSZbZHf3D6dnHz2dh2KYMYpnPqnIGwOtfeYyOwkX2iZh9k5RWrCxuo1seHjx1lLmDbqjqLjp6730U99AqMAdb5uCOObhlDu6Yg3vMwbvMeYkXBgeSYLPBwBtcd02v7qPzN68Xs9PYP3QjliTN6lgqSThjZTnRkimQ1wnj3IoaoqVUcPOSTUohJKVKKZ0wBv_2ssxBNWYiF4qkD9BBZSp1gnCuJiNOcp1DPLBaSZSUCZWMhVClpDwdoCj0YnHlaqsUwXS4Lmz3F7b7YZJaQPcPEAsdXXh16FRfAVz54-eeB1QKCJ12P4xXyjTfCpDONCd2hj1ADx1c298RkH6098xjdNzx_gk6qDeNegoCtRbPPLV-AtKOkpY |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patients+With+Resectable+NSCLC+Undergoing+Neoadjuvant+Chemoimmunotherapy%3A+To+Adjuvant+or+Not+to+Adjuvant%3F&rft.jtitle=Journal+of+thoracic+oncology&rft.au=Wu%2C+Peng&rft.au=Li%2C+Dongyu&rft.au=Zhang%2C+Chaoqi&rft.au=Sun%2C+Nan&rft.date=2025-03-01&rft.eissn=1556-1380&rft.volume=20&rft.issue=3&rft.spage=e41&rft_id=info:doi/10.1016%2Fj.jtho.2024.11.017&rft_id=info%3Apmid%2F40049767&rft.externalDocID=40049767 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-0864&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-0864&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-0864&client=summon |